Racial and ethnic disparities in brain tumour survival by age group and tumour type

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin 2020;70:7–30.
   PubMed Web of Science ®Google Scholar
• Holmes L, Jr., Chavan P, Blake T, Dabney K. Unequal cumulative incidence and mortality outcome in childhood brain and central nervous system malignancy in the USA. J Racial and Ethnic Health Disparities 2018;5:1131–41.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Cioffi G, Gittleman H, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016. Neuro Oncol 2019;21:v1–v100.
   PubMed Web of Science ®Google Scholar
• Curry WT, Jr., Carter BS, Barker FG. 2nd. Racial, ethnic, and socioeconomic disparities in patient outcomes after craniotomy for tumor in adult patients in the United States, 1988-2004. Neurosurgery 2010;66:427–37; discussion 437–428.
   PubMed Web of Science ®Google Scholar
• Berkman LF, Kawachi I, Social epidemiology. New York: Oxford University Press; 2000.
   Google Scholar
• Delavar A, Al Jammal OM, Maguire KR, Wali AR, Pham MH. The impact of rural residence on adult brain cancer survival in the United States. J Neurooncol 2019;144:535–43.
   PubMed Web of Science ®Google Scholar
• Lopez Ramos C, Brandel MG, Steinberg JA, et al. The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma. J Neurooncol 2019;141:159–66.
   PubMed Web of Science ®Google Scholar
• Lurie N, Dubowitz T. Health disparities and access to health. JAMA 2007;297:1118–21.
   PubMed Web of Science ®Google Scholar
• Bytnar JA, Lin J, Shriver CD, Zhu K. Racial differences in brain cancer characteristics and survival: an analysis of SEER data. Cancer Causes Control 2019;30:1283–91.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Cote DJ, Ascha M, Kruchko C, Barnholtz-Sloan JS. Adult glioma incidence and survival by race or ethnicity in the united states from 2000 to 2014. JAMA Oncol 2018;4:1254–62.
   PubMed Web of Science ®Google Scholar
• Pan IW, Ferguson SD, Lam S. Patient and treatment factors associated with survival among adult glioblastoma patients: a USA population-based study from 2000-2010. J Clin Neurosci 2015;22:1575–81.
   PubMed Web of Science ®Google Scholar
• McFaline-Figueroa JR, Lee EQ. Brain tumors. Am J Med 2018;131:874–82.
   PubMed Web of Science ®Google Scholar
• Robertson JT, Gunter BC, Somes GW. Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg 2002;16:562–6.
   PubMed Web of Science ®Google Scholar
• Barnholtz-Sloan JS, Sloan AE, Schwartz AG. Racial differences in survival after diagnosis with primary malignant brain tumor. Cancer 2003;98:603–9.
   PubMed Web of Science ®Google Scholar
• Barnholtz-Sloan JS, Maldonado JL, Williams VL, et al. Racial/ethnic differences in survival among elderly patients with a primary glioblastoma. J Neurooncol 2007;85:171–80.
   PubMed Web of Science ®Google Scholar
• Tehranifar P, Goyal A, Phelan JC, et al. Age at cancer diagnosis, amenability to medical interventions, and racial/ethnic disparities in cancer mortality. Cancer Causes Control 2016;27:553–60.
   PubMed Web of Science ®Google Scholar
• Surveillance Epidemiology and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database name = Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2017 Sub (1973-2016 varying) - Linked To County Attributes - Total U.S., 1969-2016 Counties.
   Google Scholar
• Surveillance Epidemiology and End Results Site Recode ICD-O-3/WHO 2008 Definition. https://seer.cancer.gov/siterecode/icdo3_dwhoheme/. Accessed September 10th, 2020.
   Google Scholar
• Yu M, Tatalovich Z, Gibson JT, Cronin KA. Using a composite index of socioeconomic status to investigate health disparities while protecting the confidentiality of cancer registry data. Cancer Causes Control 2014;25:81–92.
   PubMed Web of Science ®Google Scholar
• Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V, Mathoulin-Pélissier S. Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer. BMC Med Res Methodol 2010;10:20.
   PubMed Web of Science ®Google Scholar
• Chin AL, Moding EJ, Donaldson SS, et al. Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma. Neuro Oncol 2018;20:1133–41.
   PubMed Web of Science ®Google Scholar
• Syed ST, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J Community Health 2013;38:976–93.
   PubMed Web of Science ®Google Scholar
• Cooney T, Fisher PG, Tao L, Clarke CA, Partap S. Pediatric neuro-oncology survival disparities in California. J Neurooncol 2018;138:83–97.
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Zaidi HA, Kosztowski T, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg 2010;145:247–53.
   PubMedGoogle Scholar
• Lee EQ, Chukwueke UN, Hervey-Jumper SL, et al. Barriers to accrual and enrollment in brain tumor trials. Neuro Oncol 2019;21:1100–17.
   PubMed Web of Science ®Google Scholar
• Lynch JC, Welling L, Escosteguy C, Pereira AG, Andrade R, Pereira C. Socioeconomic and educational factors interference in the prognosis for glioblastoma multiform. Br J Neurosurg 2013;27:80–3.
   PubMed Web of Science ®Google Scholar
• Deshpande AD, Jeffe DB, Gnerlich J, Iqbal AZ, Thummalakunta A, Margenthaler JA. Racial disparities in breast cancer survival: an analysis by age and stage. J Surg Res 2009;153:105–13.
   PubMed Web of Science ®Google Scholar
• San Miguel Y, Gomez SL, Murphy JD, et al. Age-related differences in breast cancer mortality according to race/ethnicity, insurance, and socioeconomic status. BMC Cancer 2020;20:228.
   PubMed Web of Science ®Google Scholar
• Tarney CM, Tian C, Wang G, et al. Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol 2018;149:12–21.
   PubMed Web of Science ®Google Scholar
• He T, Mullins CD. Age-related racial disparities in prostate cancer patients: a systematic review. Ethn Health 2017;22:184–95.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. Ambulatory Care Use and Physician office visits, https://www.cdc.gov/nchs/fastats/physician-visits.htm. Published 2018. Accessed.
   Google Scholar
• Wilkins CH, Schindler SE, Morris JC. Addressing health disparities among minority populations: why clinical trial recruitment is not enough. JAMA Neurol 2020;77:1063.
   PubMed Web of Science ®Google Scholar
• Patel NP, Lyon KA, Huang JH. The effect of race on the prognosis of the glioblastoma patient: a brief review. Neurol Res 2019;41:967–71.
   PubMed Web of Science ®Google Scholar
• Deorah S, Lynch CF, Sibenaller ZA, Ryken TC. Trends in brain cancer incidence and survival in the United States: surveillance, epidemiology, and end results program, 1973 to 2001. Neurosurg Focus 2006;20:E1.
   PubMedGoogle Scholar
• Thakkar JP, Dolecek TA, Horbinski C, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 2014;23:1985–96.
   PubMed Web of Science ®Google Scholar
• Wu M, Miska J, Xiao T, et al. Race influences survival in glioblastoma patients with KPS >/= 80 and associates with genetic markers of retinoic acid metabolism. J Neurooncol 2019;142:375–84.
   PubMed Web of Science ®Google Scholar
• Wiencke JK, Aldape K, McMillan A, et al. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 2005;14:1774–83.
   PubMed Web of Science ®Google Scholar
• Yang H, Wei D, Yang K, Tang W, Luo Y, Zhang J. The prognosis of MGMT promoter methylation in glioblastoma patients of different race: a meta-analysis. Neurochem Res 2014;39:2277–87.
   PubMed Web of Science ®Google Scholar
• Zarnett OJ, Sahgal A, Gosio J, et al. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis. JAMA Neurol 2015;72:589–96.
   PubMed Web of Science ®Google Scholar
• Dai Y, Ning X, Han G, Li W. Assessment of the association between isocitrate dehydrogenase 1 mutation and mortality risk of glioblastoma patients. Mol Neurobiol 2016;53:1501–8.
   PubMed Web of Science ®Google Scholar
• Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012;483:479–83.
   PubMed Web of Science ®Google Scholar
• Yan H, Parsons DW, Jin G, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med 2009;360:765–73.
   PubMed Web of Science ®Google Scholar
• Shabihkhani M, Telesca D, Movassaghi M, et al. Incidence, survival, pathology, and genetics of adult Latino Americans with glioblastoma. J Neurooncol 2017;132:351–8.
   PubMed Web of Science ®Google Scholar
• Gupta R, Flanagan S, Li CC, et al. Expanding the spectrum of IDH1 mutations in gliomas. Mod Pathol 2013;26:619–25.
   PubMed Web of Science ®Google Scholar
• Gupta S, Aitken JF, Bartels U, et al. Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines. Lancet Oncol 2016;17:e163–e172.
   PubMed Web of Science ®Google Scholar
• Colton MD, Hawkins M, Goulding D, Cockburn M, Green AL. Socioeconomics, race, and ethnicity in childhood cancer survival: accessing and addressing root causes of disparities. Cancer 2018;124:3975–8.
   PubMed Web of Science ®Google Scholar
• Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 2021;23:1231–51.
   PubMed Web of Science ®Google Scholar
• Delavar A, Barnes JM, Wang X, Johnson KJ. Associations between race/ethnicity and US childhood and adolescent cancer survival by treatment amenability. JAMA Pediatr 2020;174:428–36.
   PubMed Web of Science ®Google Scholar